Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Seido Capital is a venture capital firm founded in 2024 and based in North America. The firm is dedicated to supporting innovators in the life sciences and deep tech sectors. Seido Capital provides not only capital but also strategic guidance and expertise to help transform groundbreaking ideas into market leaders. The firm has quickly established itself as a key player in the investment landscape, focusing on sectors that are critical to advancing healthcare and technology.
Currently, Seido Capital manages assets totaling $150 million. The firm invests across various stages, including pre-seed, seed, Series A, Series B, Series C, pre-IPO, and IPO. This diverse investment strategy allows Seido Capital to engage with companies at different points in their growth trajectories. The firm is committed to leveraging cross-border partnerships to foster sustainable growth in its portfolio companies.
Seido Capital's investment strategy is centered around life sciences and deep tech, with a particular emphasis on sectors such as biotech, medical devices, diagnostics, and digital health tools. The firm seeks to invest in companies at various stages, from pre-seed to IPO, ensuring that they can support innovators throughout their development journey. Seido Capital looks for pioneering technologies and data-driven solutions that have the potential to disrupt traditional markets and improve patient outcomes.
In addition to financial backing, Seido Capital provides strategic insights and operational support to its portfolio companies. The firm values partnerships that enhance growth opportunities and is particularly interested in companies that demonstrate a clear path to market leadership. Their approach includes a focus on sustainable growth through innovative solutions that address pressing healthcare challenges.
Seido Capital's portfolio includes a range of companies that are making significant strides in diagnostics, digital therapeutics, and AI technologies. While specific names and outcomes of portfolio companies are not disclosed, the firm is known for investing in cutting-edge innovations that are poised to transform the healthcare landscape. The focus on digital health tools and advanced diagnostics reflects Seido Capital's commitment to supporting technologies that improve patient care and operational efficiencies.
Investments in transformative AI technologies further illustrate the firm's dedication to backing companies that leverage data and analytics to drive healthcare advancements. This strategic focus positions Seido Capital as a vital partner for startups aiming to make impactful contributions to the life sciences and deep tech sectors.
Olivier Belenger - Managing Partner. Olivier has extensive experience in venture capital and has led numerous investments in the life sciences and deep tech sectors. His background includes roles at notable investment firms where he focused on identifying and supporting innovative companies. Olivier holds a degree in a relevant field, enhancing his expertise in evaluating technology-driven startups.
To pitch to Seido Capital, founders should visit their website at Seido Capital's website. It is recommended to include a clear overview of the business model, market opportunity, and team qualifications in the pitch deck. Response times may vary, so founders should be prepared for a range of timelines.
What are Seido Capital's investment criteria?
Seido Capital invests in life sciences and deep tech companies at various stages, including pre-seed, seed, Series A, B, C, pre-IPO, and IPO. The firm emphasizes sectors such as biotech, medical devices, diagnostics, and digital health tools.
How can I apply or pitch to Seido Capital?
Founders interested in pitching to Seido Capital can visit their website at Seido Capital's website for more information on the application process.
What makes Seido Capital different from other venture firms?
Seido Capital distinguishes itself through its focus on life sciences and deep tech, providing not only capital but also strategic expertise to help companies grow. Their commitment to cross-border partnerships enhances the growth potential of their portfolio companies.
What is Seido Capital's geographic scope?
The firm primarily invests in North America, targeting innovative companies that are developing solutions in life sciences and deep tech.
What is Seido Capital's approach to post-investment involvement?
Seido Capital actively engages with its portfolio companies, offering strategic guidance and operational support to help them navigate challenges and capitalize on growth opportunities.
What is the typical check size for investments?
While specific check sizes are not disclosed, Seido Capital invests across various stages, indicating a flexible approach to funding based on the needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.